Viewing StudyNCT03838367



Ignite Creation Date: 2024-05-06 @ 12:44 PM
Last Modification Date: 2024-10-26 @ 1:03 PM
Study NCT ID: NCT03838367
Status: UNKNOWN
Last Update Posted: 2022-03-21
First Post: 2019-02-05

Brief Title: Leronlimab PRO 140 Combined With Carboplatin in Patients With CCR5 mTNBC
Sponsor: CytoDyn Inc
Organization: CytoDyn Inc

Conditions & Keywords Data

Conditions:
Name
Triple Negative Breast Neoplasms
Keywords:
Name View
PRO 140 View
TNBC View